Use of highly encapsulated Streptococcus pneumoniae strains in a flow- cytometric assay for assessment of the phagocytic capacity of serotype- specific antibodies

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 5, 1998, Pages 703-710

  Jansen, W T M ^a   Gootjes, J ^a   Zelle, M ^a   Madore, D V ^b   Verhoef, J ^a   Snippe, H ^a   Verheul, A F M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Wyeth Lederle Vaccines   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYSACCHARIDE; POLYSACCHARIDE ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; COMPETITIVE INHIBITION; FEMALE; FLOW CYTOMETRY; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RABBIT; SERODIAGNOSIS; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0032434029     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.5.703-710.1998     Document Type: Article

References (38)

1. Alonso de Velasco, E., A. F. M. Verheul, A. M. P. van Steijn, H. A. T. Dekker, R. G. Feldman, I. M. Fernández, J. P. Kamerling, J. F. Vliegenthart, J. Verhoef, and H. Snippe. 1994. Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG. Infect. Immun. 62:799-808.
2. Alonso De Velasco, E., H. A. Dekker, P. Antal, K. P. Jalink, J. A. van Strijp, A. F. M. Verheul, J. Verhoef, and H. Snippe. 1994. Adjuvant Ouil A improves protection in mice and enhances opsonic capacity of antisera induced by pneumococcal polysaccharide conjugate vaccines. Vaccine 12:1419-1422.
3. Alonso De Velasco, E., B. A. Dekker, A. F. M. Verheul, R. G. Feldman, J. Verhoef, and H. Snippe. 1995. Anti-polysaccharide immunoglobulin isotype levels and opsonic activity of antisera: relationships with protection against Streptococcus pneumoniae infection in mice. J. Infect. Dis. 172:562-565.
4. Alonso De Velasco, E., A. F. M. Verheul, J. Verhoef, and H. Snippe. 1995. Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. Microbiol. Rev. 59:591-603.
5. Bardardottir, E., S. Jonsson, I. Jonsdottir, A. Sigfusson, and H. Valdimarsson. 1990. IgG subclass response and opsonization of Streptococcus pneumoniae after vaccination of healthy adults. J. Infect. Dis. 162:482-488.
6. Böyum, X. 1986. Isolation of mononuclear cells and granulocytes from human blood. Scand. J. Clin. Lab. Investig. Suppl. 97:77-89.
7. Braconier, J. H., F. K. Pedersen, H. Odeberg, and C. Rosen. 1984. Opsonic and antibody responses to pneumococcal polysaccharide types 6A, 19F and 23F after vaccination of immunocompromised patients. Scand. J. Infect. Dis. 16:161-167.
8. Briles, D. E., C. Forman, J. C. Horowitz, J. E. Volanakis, W. H. Benjamin, Jr., L. S. McDaniel, J. Eldridge, and J. Brooks. 1989. Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens. Infect. Immun. 57:1457-1464.
9. Brown, E. J., K. A. Joiner, R. M. Cole, and M. Berger. 1983 Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococeal capsule. Infect. Immun. 39:403-409.
10. Chan, C. Y., D. C. Molrine, S. George, N. J. Tarbell, P. Mauch, L. Diller, R. C. Shamberger, N. R. Phillips, A. Goorin, and D. M. Ambrosino. 1996. Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease. J. Infect. Dis. 173:256-258.
11. Chudwin, D. S., S. G. Artrip, A. Korenblit, G. Schiffman, and S. Rao. 1985. Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniae. Infect. Immun. 50:213-217.
12. Coonrod, J. D., R. Varble, and K. Yoneda. 1991. Mechanism of killing of pneumococci by lysozyme. J. Infect. Dis. 164:527-532.
13. Dixon, J. M., and A. E. Lipinski. 1981. Pneumococcal serotypes causing bacteremia and meningitis: relevance to composition of pneumococcal vaccine. Can. Med. Assoc. J. 125:263-267.
14. Fine, D. P., J. L. Kirk, G. Schiffman, J. E. Schweinle, and J. C. Guckian. 1988. Analysis of humoral and phagocytic defenses against Streptococcus pneumoniae serotypes 1 and 3. J. Lab. Clin. Med. 112:487-497.
15. Finland, M., and M. W. Barnes. 1977. Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974. J. Clin. Microbiol. 5:154-166.
16. Gardner, S. E., D. C. Anderson, B. J. Webb, A. E. Stitzel, M. S. Edwards, R. E. Spitzer, and C. J. Baker. 1982. Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay. Infect. Immun. 35:800-808.
17. Giebink, G. S., J. E. Foker, Y. Kim, and G. Schiffman. 1980. Serum antibody and opsonic responses to vaccination with pneumococcal capsular polysaccharide in normal and splenectomized children. J. Infect. Dis. 141:404-412.
18. Giebink, G. S., M. Koskela, P. P. Vella, M. Harris, and C. T. Le. 1993. Pneumococcal capsular polysaccharide-meningococcal outer membrane protein complex conjugate vaccines: immunogenicity and efficacy in experimental pneumococcal otitis media. J. Infect. Dis. 167:347-355.
19. Giebink, G. S., J. Verhoef, P. K. Peterson, and P. G. Quie. 1977. Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV. Infect. Immun. 18:291-297.
20. Hamill, R. J., D. M. Musher, J. E. Groover, P. J. Zavell, and D. A. Watson. 1992. IgG antibody reactive with five serotypes of Streptococcus pneumoniae in commercial intravenous immunoglobulin preparations. J. Infect. Dis. 166: 38-42.
21. Hof, D. G., J. E. Repine, G. S. Giebink, and J. R. Hoidal. 1981. Production of opsonins that facilitate phagocytosis of Streptococcus pneumoniae by human alveolar macrophages or neutrophils after vaccination with pneumococcal polysaccharide. Am. Rev. Respir. Dis. 124:193-195.
22. Johansen, K. S., and F. K. Pedersen. 1982. Antibody response and opsonization after pneumococcal vaccination in splenectomized children and healthy persons. Acta Pathol. Microbiol. Immunol. Scand. Sect. C 90:265-270.
23. Klerx, J. P. A. M., C. J. Beukelman, H. V. Dijk, and J. Willers. 1983. Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum. J. Immunol. Methods 63:215.
24. Koskela, M. 1987. Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination. Pediatr. Infect. Dis. J. 6:519-526.
25. Moulin, A., J. Fleurette, and G. Ekong. 1979. Serotypie des pneumocoques isoles dans les produits pathologiques au cours de deux periodes, 1972-1977 et 1978. Pathol. Biol. 27:567-570.
26. Musher, D. M., A. J. Chapman, A. Goree, S. Jonsson, D. Briles, and R. E. Baughn. 1986. Natural and vaccine-related immunity to Streptococcus pneumoniae. J. Infect. Dis. 154:245-256.
27. Musher, D. M., D. A. Watson, and R. E. Baughn. 1990. Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection? J. Infect. Dis. 161:736-740.
28. Nielsen, S. V., U. B. Sorensen, and J. Henrichsen. 1993. Antibodies against pneumococcal C-polysaccharide are not protective. Microb. Pathog. 14:299-305.
29. Obaro, S. K., D. C. Henderson, and M. A. Monteil. 1996. Defective antibody-mediated opsonisation of S. pneumoniae in high risk patients detected by flow cytometry. Immunol. Lett. 49:83-89.
30. Paoletti, L. C., D. L. Kasper, F. Michon, J. DiFabio, H. J. Jennings, T. D. Tosteson, and M. R. Wessels. 1992. Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates. J. Clin. Invest. 89:203-209.
31. Pedersen, F. K., J. Henrichsen, U. B. Sorensen, and J. L. Nielsen. 1982. Anti-C-carbohydrate antibodies after pneumococcal vaccination. Acta Pathol. Microbiol. Immunol. Scand. Sect. C 90:353-355.
32. Quataert, S. A., C. S. Kirch, L. J. Quackenbush Wiedl, D. C. Phipps, S. Strohmeyer, C. O. Cimino, J. Skuse, and D. V. Madore. 1995. Assignment of weight-based antibody units to a human antipneumococcal standard refer-ence serum, lot 89-S. Clin. Diagn. Lab. Immunol. 2:590-597.
33. Romero-Steiner, S., D. Libutti, L. B. Pais, J. Dykes, P. Anderson, J. C. Whitin, H. L. Keyserling, and G. M. Carlone. 1997. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells. Clin. Diagn. Lab. Immunol. 4:415-422.
34. Sihiffman, G., R. M. Douglas, M. J. Bonner, M. Robbins, and R. Austrian. 1980. A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Methods for the radioimmunoassay of anticapsular antibodies and comparison with other techniques. J. Immunol. Methods 33:133-144.
35. Shelly, M. A., H. Jacoby, G. J. Riley, B. T. Graves, M. Pichichero, and J. J. Treanor. 1997. Comparison of pneumococcal polysaccharide and CRM197. conjugated pneumococcal oligosaccharide vaccines in young and elderly adults. Infect. Immun. 65:242-247.
36. Sjogren, A., B. Lindholm, and T. Holme. 1987. Availability of reaction with antibodies of the pneumococcal C-polysaccharide on the surface of capsulated pneumococci. Acta Pathol. Microbiol. Immunol. Scand. Sect. B 95: 371-378.
37. 36a. Verheul, A. F. M., et al. Unpublished results.
38. Viôarsson, G., I. Jonsdottir, S. Jonsson, and H. Valdimarsson. 1994. Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumonias. J. Infect. Dis. 170:592-599.